Our Undergraduate Student, Levina Lin, receives a Dean’s Prize at Research Poster Day 2018. Congratulations, Levina!
Our two outstanding undergraduate students, Alex Pham and Levina Lin, are both accepted into the UCLA Medical School. Congratulations, Alex and Levina!
Dr. Jessie Xiao Ma joins us as a postdoc. Welcome, Jessie!
Dr. Yu Jeong Kim joins us as a postdoc. Welcome, YJ!
Dr. Lili Yang and Dr. Yu Huang jointly receive a $150,000 BSCRC/CNSI Stem Cell Nano-Medicine Initiative Planning Award from UCLA, to study the in vitro expansion of human blood stem cells using decorated graphene as feeders.
Our paper on miR-146a regulation of Th17 polarization and autoimmunity is published online on the Journal of Clinical Investigation. Congratulations to all the authors, in particular to the co-first authors Bo Li & Shirley Xi Wang! [PDF][Link]
Our PhD trainee, Dr. Drake Smith, joins the Gilead/Kite Pharma as a Scientist. Congratulations, Drake!
Our first PhD student, Drake Smith, successfully defended his thesis today. He sets a record of completing a productive PhD training in 4 years. Congratulations, Dr. Smith!
Our Postdoc trainee, Dr. Inyoung Choi, joins Booz Allen Hamilton as a Senior Consultant. Congratulations, Inyoung!
Dr. Lili Yang receives the Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT). [PDF][Link]
Dr. Lili Yang receives the Life Sciences Faculty Excellence Award for Outstanding Research Publication from UCLA.
Dr. Lili Yang receives the Young Investigator Award from the American Association of Immunologist (AAI).
Our paper on propagating humanized BLT mice for the study of human immunotherapy is published online on the journal of Stem Cells and Development. Congratulations to all the authors, in particular to the first author Drake Smith! [ Link ] [ PDF ]
Alice Yang Zhou joins us as a Lab Manager and Research Assistant. Welcome, Alice!
Dr. Lili Yang receives a $150,000 BSCRC-RHF Research Award from the Rose Hills Foundation (RHF) to study human iNKT cell development.
Our Postdoc trainee, Dr. Bo Li, joins the Loma Linda University as an Assistant Professor. Congratulations, Bo!
Dr. Lili Yang receives a $7.6M CIRM 2.0 Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-based immunotherapy into clinics. [PDF][Link]
Our former Lab Manager, Claret Siyuan Liu, joins Amgen as a Scientist. Congratulations, Claret!
Our PhD Student, Drake Smith, receives a T32 Tumor Immunology Training Grant. Congratulations, Drake!
Drs. David Baltimore, Owen Witte, and Lili Yang jointly receive a $1M GTSN Challenge Award for Lethal Prostate Cancer from the Prostate Cancer Foundation (PCF), to study T cell receptor gene therapy for treatment of lethal prostate cancer.
Our PNAS paper on stem cell-engineering iNKT cells is listed as the TOP STORY on the Hematopoiesis News. [PDF][Link]
Our paper on stem cell-engineered invariant natural killer T (iNKT) cells is published online on PNAS. Congratulations to all the authors, in particular to the first author Drake Smith! [PDF][Link]
Dr. Lili Yang receives a $150,000 STOP CANCER Research Career Development Award to study tumor immunology and cancer immunotherapy. [PDF][Link]
Dr. Lili Yang receives a $2.3M NIH Director’s New Innovator (DP2) Award to develop new ways using blood stem cells to attack cancer. [PDF][Link]
Dr. Lili Yang receives a $50,000 Stem Cell Research Award from the Concern Foundation, to study stem cell-engineered iNKT cell therapy for breast cancer.
Dr. Lili Yang receives a $614,400 CIRM Basic Biology V Exploratory Concepts (RB5) Award to study special immune cells. [PDF][Link]
Dr. Lili Yang receives a $65,000 SPORE in Prostate Cancer Career Development Award (NIH P50), to study stem cell-engineered iNKT cells for prostate cancer therapy.
Dr. Lili Yang receives a $50,000 BSCRC Innovation Award from UCLA, to study stem cell engineering for immunotherapy.
Dr. Lili Yang is named as one of the 35 Innovators Under 35 (TR35) by the MIT Technology Review Magazine. [PDF][Link]